Transcatheter Aortic Valve Replacement (TAVR) | CMS Coverage Update

Summary: The Centers for Medicare & Medicaid Services modified its Transcatheter Aortic Valve Replacement (TAVR) coverage policy, with an effective date of May 15, 2026. Here's what billing teams need to do.

CMS updated its TAVR coverage policy governing one of the most financially significant cardiac procedures in the Medicare program. The Centers for Medicare & Medicaid Services has not published specific CPT or HCPCS codes in the policy data available at the time of this writing — we'll flag those as they appear. What billing teams need to understand now is the scope of this change, what it means for medical necessity documentation, and how to prepare your revenue cycle before May 15, 2026.

Quick-Reference Table

CMS TAVR Coverage Criteria and Medical Necessity Requirements 2026

TAVR billing sits at the intersection of high reimbursement, strict medical necessity requirements, and close CMS scrutiny. This is not a low-stakes coverage policy. A single denied TAVR claim can represent tens of thousands of dollars in lost reimbursement for your facility.

CMS has historically tied TAVR coverage to specific facility and operator volume standards, heart team requirements, and patient-level criteria. The core medical necessity framework under the National Coverage Determination governing TAVR requires that patients be evaluated by a multidisciplinary heart team before any procedure goes forward. That requirement has not gone away — and modifications to this coverage policy typically tighten the documentation trail around it.

Medical necessity for TAVR under CMS has centered on symptomatic aortic stenosis, surgical risk stratification, and heart team consensus. If your documentation doesn't explicitly reflect each of those elements, your claim is exposed. The modification effective May 15, 2026 is the right moment to pressure-test your intake-to-claim workflow against the updated criteria.

Whether CMS is expanding covered indications, adjusting registry requirements, or revising facility standards, the practical effect for billing teams is the same: your pre-service documentation and prior authorization workflows need to reflect whatever the updated coverage policy requires before the first claim goes out under the new rules.

Prior authorization is not universally required for TAVR under Medicare fee-for-service, but Medicare Advantage plans that follow CMS guidance often impose their own prior auth overlays. If your program treats a mixed Medicare population, verify whether your MA contracts add prior authorization requirements on top of the underlying CMS policy. Don't assume fee-for-service rules apply to your MA volume.

CMS TAVR Exclusions and Non-Covered Indications

CMS has consistently limited TAVR coverage to specific anatomical indications and patient risk profiles. Coverage does not extend to valve replacement for conditions other than native aortic stenosis unless explicitly addressed in the updated policy language.

Valve-in-valve procedures — using TAVR to replace a failed bioprosthetic aortic valve — have had a complicated coverage history under CMS. CMS expanded valve-in-valve coverage in prior NCD updates, but the documentation requirements differ from native valve TAVR. If your program performs valve-in-valve procedures, audit those claims separately.

Procedures performed outside of CMS-approved facility standards — including volume thresholds and registry participation requirements — have historically been non-covered. This is the area where claim denial risk is highest and where many programs have exposure they don't know about. If your facility recently started a TAVR program or experienced volume fluctuations, review your compliance with facility requirements before May 15, 2026.

Coverage Indications at a Glance

The policy data provided does not include indication-level detail in the available summary. The table below reflects the established CMS TAVR coverage framework and should be verified against the full updated policy text at the effective date.

Verify every row against the full policy text before May 15, 2026. If your compliance officer hasn't reviewed the updated NCD language, that review needs to happen now.

CMS TAVR Billing Guidelines and Action Items 2026

TAVR billing guidelines require coordination across your cardiac surgery, cardiology, hospital coding, and CDI teams. A policy modification this significant is not something your coder handles alone. Here's what your team needs to do before May 15, 2026.

CPT, HCPCS, and ICD-10 Codes for TAVR Under This Policy

The policy data provided does not list specific CPT, HCPCS, or ICD-10 codes. Do not bill based on assumed codes from prior policy versions without confirming against the updated CMS policy text.

The table below identifies the code categories your billing team should confirm once the full policy text is available.

Code Categories to Verify Before May 15, 2026

Confirm every code category against the full updated CMS policy text before May 15, 2026. If your coding team isn't sure which codes are affected by the modification, this is the right time to bring in a billing consultant who specializes in structural heart procedures.